Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DSM-5 and clinical trials in psychiatry: challenges to come?
Butlen-Ducuing F, Haas M, Pani L, van Zwieten-Boot B, Broich K. Butlen-Ducuing F, et al. Among authors: haas m. Nat Rev Drug Discov. 2012 Aug;11(8):583-4. doi: 10.1038/nrd3811. Nat Rev Drug Discov. 2012. PMID: 22850770
Stakeholder collaboration for spinal muscular atrophy therapy development.
Aartsma-Rus A, Balabanov P, Binetti L, Haas M, Haberkamp M, Mitchell J, Rosa MM, Muntoni F, Finkel R, Mercuri E. Aartsma-Rus A, et al. Among authors: haas m. Lancet Neurol. 2017 Apr;16(4):264. doi: 10.1016/S1474-4422(17)30041-8. Lancet Neurol. 2017. PMID: 28327335 No abstract available.
European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene.
Haas M, Vlcek V, Balabanov P, Salmonson T, Bakchine S, Markey G, Weise M, Schlosser-Weber G, Brohmann H, Yerro CP, Mendizabal MR, Stoyanova-Beninska V, Hillege HL. Haas M, et al. Neuromuscul Disord. 2015 Jan;25(1):5-13. doi: 10.1016/j.nmd.2014.11.011. Epub 2014 Nov 24. Neuromuscul Disord. 2015. PMID: 25497400 No abstract available.
Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues.
Aartsma-Rus A, Straub V, Hemmings R, Haas M, Schlosser-Weber G, Stoyanova-Beninska V, Mercuri E, Muntoni F, Sepodes B, Vroom E, Balabanov P. Aartsma-Rus A, et al. Among authors: haas m. Nucleic Acid Ther. 2017 Oct;27(5):251-259. doi: 10.1089/nat.2017.0682. Epub 2017 Aug 10. Nucleic Acid Ther. 2017. PMID: 28796573 Free PMC article. Review.
2,149 results